CIK 0001339970
- Non-accelerated filer
- Smaller reporting company
aTYR PHARMA INC
Sign in to watch- Ticker
- ATYR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 203435077
- Phone
- +1 858-731-8389
- Business address
- 10240 SORRENTO VALLEY ROAD, SUITE 300, SAN DIEGO, CA, 92121
- 4 Open-market buy Director bought 85,000 shares at $3.22 ($273,649)
- 4 Open-market buy Director bought 40,000 shares at $3.19 ($127,584)
- 4 Open-market buy Director bought 25,000 shares at $3.20 ($80,000)
- 4 Open-market buy CEO and Director bought 2,500 shares at $3.52 ($8,800)
- 4 Open-market buy CEO and Director bought 2,500 shares at $3.55 ($8,875)
- 4 Open-market buy Director bought 25,000 shares at $3.52 ($88,118)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Gift Director gave 11,925 shares (gift)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 12 of 17 · 329 filings